Skip to Main Content

Sandy W. Wong



Dr. Sandy Wong is a blood disease specialist who cares for people with MGUS (monoclonal gammopathy of undetermined significance), smoldering myeloma, multiple myeloma and amyloidosis, a condition in which an abnormal protein called amyloid builds up in the body.

Wong has a special interest in amyloidosis patients, and her research focuses on that disease. She studies patients with AL amyloidosis (the most common type) whose kidneys are affected, as well as those with chromosomal abnormalities. She also is designing a clinical trial for a promising new drug to treat multiple myeloma.

After graduating from Brown University with a degree in human biology, Wong earned her medical degree at the University of Massachusetts. She then completed an internal medicine residency followed by a hematology-oncology fellowship at Tufts Medical Center.

Wong is a member of the American Society of Hematology and American Society of Clinical Oncology.

  • Education

    University of Massachusetts, 2009

  • Residencies

    Tufts Medical Center, Internal Medicine, 2012

  • Fellowships

    Tufts Medical Center, Hematology-Oncology, 2016

  • Board Certifications

    Hematology, American Board of Internal Medicine

  • Languages



Where I see patients (1)

    My reviews


    Overall Experience
    309 Ratings
    Explained things in a way that was easy to understand
    309 Ratings
    Did the doctor pay attention to your concerns
    309 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    303 Ratings
    Knew the important information about your medical history
    308 Ratings
    The provider showed respect for what you had to say
    305 Ratings
    The provider spent enough time with me
    307 Ratings
    Decorative Caduceus

    A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

    An AE can be any unfavorable and unintended sign (including an abnormal finding), symptom, or disease temporally associated with the use of a medicinal (investigational or non-investigational) product, whether or not related to th...


    Decorative Caduceus

    Screening to Improve Survival in AL Amyloidosis

    By creating a multicenter network (N =6) we will have study centers in Massachusetts (1), California (2), New York (1), North Carolina (1) and Florida (1), enabling us to evaluate 50 patients 60 or older with λ SMM or λ MGUS and t...


    Decorative Caduceus

    Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodoti...

    Corneal tissue samples will be collected to evaluate the composition of microcyst-like epithelium observed in participants treated with belantamab mafodotin.